Literature DB >> 31227567

Optic neuropathy as the first sign of central nervous system relapse in acute myeloid leukaemia: MRI findings and its diagnostic challenge.

Michelle Cheung1, Benjamin Fang1, Raymand Lee1.   

Abstract

We describe the case of a 22-year-old man who presented with right eye visual impairment and oral mucositis. MRI revealed findings compatible with right optic neuritis. Herpes simplex virus 1 was detected in oral swab. He has a previous history of acute myeloid leukaemia (AML) and was in clinical remission. Initial investigations for possible relapse of AML with central nervous system (CNS) involvement were negative. Treatment for HSV-related optic neuritis was initiated but the patient's vision deteriorated. Repeat MRI revealed right optic nerve infarct, new left optic nerve abnormality and new leptomeningeal enhancement in the brain. Repeated cerebrospinal fluid analysis confirmed CNS relapse of AML. Despite prompt initiation of pulse steroid and high dose intrathecal cytarabine followed by cranial irradiation, the patient never regained his vision. We present a case of unexpected optic neuropathy as first and sole presentation of CNS relapse of AML. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cns cancer; neuroimaging; neuroopthalmology; radiology

Mesh:

Year:  2019        PMID: 31227567      PMCID: PMC6605921          DOI: 10.1136/bcr-2018-228125

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Optic nerve biopsy in the management of progressive optic neuropathy.

Authors:  Marc H Levin; Joshua J Ney; Sriram Venneti; Mark L Moster; Laura J Balcer; Nicholas J Volpe; Roberta E Gausas; Grant T Liu; M Reza Vagefi; Steven L Galetta
Journal:  J Neuroophthalmol       Date:  2012-12       Impact factor: 3.042

2.  Leukemic infiltration of the optic nerve.

Authors:  R T Wallace; J A Shields; C L Shields; H Ehya; M Ewing
Journal:  Arch Ophthalmol       Date:  1991-07

3.  Cerebrospinal fluid pleocytosis: pitfalls and benefits of combined analysis using cytomorphology and flow cytometry.

Authors:  Martin Bommer; Andreas Nagy; Christine Schöpflin; Sandra Pauls; Mark Ringhoffer; Mathias Schmid
Journal:  Cancer Cytopathol       Date:  2011-01-24       Impact factor: 5.284

4.  Central nervous system involvement at first relapse in patients with acute myeloid leukemia.

Authors:  David Martínez-Cuadrón; Pau Montesinos; Mariluz Pérez-Sirvent; Amparo Avaria; Lourdes Cordón; Rebeca Rodríguez-Veiga; Guillermo Martín; Jaime Sanz; Jesús Martínez; Miguel A Sanz
Journal:  Haematologica       Date:  2011-05-12       Impact factor: 9.941

5.  Leukemic Optic Nerve Infiltration.

Authors:  Sandeep Randhawa; James Ruben
Journal:  Ophthalmology       Date:  2017-03       Impact factor: 12.079

6.  [Ophthalmic manifestations of acute leukemia].

Authors:  M Charif Chefchaouni; M Belmekki; Z Hajji; H Tahiri; R Amrani; M El Bakkali; F Msefer Alaoui; A Berraho
Journal:  J Fr Ophtalmol       Date:  2002-01       Impact factor: 0.818

7.  A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).

Authors:  R Holmes; M J Keating; A Cork; Y Broach; J Trujillo; W T Dalton; K B McCredie; E J Freireich
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

8.  Magnetic resonance imaging of optic nerve.

Authors:  Foram Gala
Journal:  Indian J Radiol Imaging       Date:  2015 Oct-Dec

9.  Acute Myeloid Leukemia Relapse Presenting as Complete Monocular Vision Loss due to Optic Nerve Involvement.

Authors:  Shyam A Patel
Journal:  Case Rep Hematol       Date:  2016-09-07

10.  Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia.

Authors:  Nael Alakel; Friedrich Stölzel; Brigitte Mohr; Michael Kramer; Uta Oelschlägel; Christoph Röllig; Martin Bornhäuser; Gerhard Ehninger; Markus Schaich
Journal:  Cancer Manag Res       Date:  2017-03-29       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.